• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Lombana, Spain

    Lombana, Spain

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Dick Dayton, USA

    Dick Dayton, USA

  • Frank Taylor, USA

    Frank Taylor, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Hollister

    Hollister
    hollister

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Ann Nicol, USA

    Ann Nicol, USA

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Anita Forte, USA

    Anita Forte, USA

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login